Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-21-001048
Filing Date
2021-02-01
Accepted
2021-02-01 17:16:01
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 azrxs3_feb12021.htm S-3 903879
2 OPINION ex5-1.htm EX-5.1 12078
3 CONSENT ex23-2.htm EX-23 4890
4 IMAGE azrxs3_feb12021000.jpg GRAPHIC 2795
5 IMAGE azrxs3_feb12021001.jpg GRAPHIC 3926
6 IMAGE ls.jpg GRAPHIC 6949
  Complete submission text file 0001654954-21-001048.txt   941208
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252623 | Film No.: 21577778
SIC: 2834 Pharmaceutical Preparations